Dr. Phillip Frost has been the Chief Executive Officer and Chairman of the company since 2007. He also serves as the Director at Cocrystal Pharma, Inc. He also served as the Director at Grove Bank & Trust and Morgan Solar. Prior to this, he served as the Chairman and Vice Chairman at Teva Pharmaceutical Industries Limited. Previously, he served as the Chairman at Key Pharmaceuticals, Inc. He served as the Chairman and Director at Ladenburg Thalmann Financial Services Inc. He also served as the Director at Continucare Corporation and Castle Brands Inc.

Dr. Elias A. Zerhouni has been the President and Vice Chairman of the company since May 2022. Prior to this, he served as the Chairman at ModeX Therapeutics Inc. Previously, he served as the Director at B-FLEXION. He served as the Chairman at Boston Pharmaceuticals. He served as the President of Global Research & Development and Executive Vice President at Sanofi from 2010 to 2018. He served as the Director at the U.S. National Institutes of Health from 2002 to 2008. He also served as the Chairman of Department Radiological Sciences at Johns Hopkins School of Medicine from 1996 to 2002. He served as the Director at Lasker Foundation and Danaher Corporation.

Dr Jane H. Hsiao has been the Vice-Chairman and Chief Technical Officer of the Company since May 2007. Prior to this, she served as the Director of the company. Previously, she served as the Chairman at Non-Invasive Monitoring Systems, Inc. Previously, she served as the Interim Chief Executive Officer at NIMS. He served as the Director at Cocrystal Pharma, Inc. He served as the Vice Chairman-Technical Affairs at IVAX from 1995 to 2006. He also served as the Chairman, Chief Executive Officer and President at IVAX Animal Health from 1998 to 2006.

Mr Gary J. Nabel has been the Chief Innovation Officer and Director since 2022. Prior to this, he served as the Chief Scientific Officer and Senior Vice President of Sanofi from 2012 to 2020. Previously, he worked as founding director of NIH’s Vaccine Research Center from 1999 to 2012. Mr Nabel worked as an investigator at the Howard Hughes Medical Institute at the University of Michigan from 1987 to 1999.

Mr. Adam Logal has been the Senior Vice President, Chief Accounting Officer, Treasurer, and the Chief Financial Officer of the company since 2014. Prior to this, he served as the Vice President of Finance, Chief Accounting Officer, and Treasurer of the company. Mr. Adam also served as the Senior Director of Accounting and Reporting of Nabi Biopharmaceuticals; the Director of VBI Vaccines Inc.